Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Azurity Pharmaceuticals, Inc with status Current. The shortage was first posted on 04/10/2020.
Shortage Details
- Status
- Current
- Company
- Azurity Pharmaceuticals, Inc
- Package NDC
- 52536-126-08
- Dosage Form
- Injection
- Presentation
- Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 52536-126-08)
- Initial Posting
- 04/10/2020
- Revised Date